{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T09:00:58Z","timestamp":1780131658116,"version":"3.54.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81974005"],"award-info":[{"award-number":["81974005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Beijing Xisike Clinical Oncology Research Foundation","award":["Y-SYBLD2022MS-0055"],"award-info":[{"award-number":["Y-SYBLD2022MS-0055"]}]},{"name":"the Joint Fund for Innovation and Development of Natural 205 Science Foundation of Hubei Province","award":["2025AFD777"],"award-info":[{"award-number":["2025AFD777"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s10096-025-05377-1","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T15:21:57Z","timestamp":1767972117000},"page":"1491-1499","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Central nervous system infections caused by carbapenem-resistant klebsiella pneumoniae after CAR T-cell therapy in a patient with preexisting colonization: a case report and literature review"],"prefix":"10.1007","volume":"45","author":[{"given":"Qing","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"5377_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-019-0591-6","volume":"8","author":"S Ambretti","year":"2019","unstructured":"Ambretti S, Bassetti M, Clerici P, Petrosillo N, Tumietto F, Viale P, Rossolini GM (2019) Screening for carriage of carbapenem-resistant Enterobacteriaceae in settings of high endemicity: a position paper from an Italian working group on CRE infections. Antimicrob Resist Infect Control 8:136. https:\/\/doi.org\/10.1186\/s13756-019-0591-6","journal-title":"Antimicrob Resist Infect Control"},{"key":"5377_CR2","doi-asserted-by":"publisher","first-page":"6821","DOI":"10.2147\/IDR.S424048","volume":"16","author":"WQ Wu","year":"2023","unstructured":"Wu WQ, Zhang YQ, Xu J, Tang ZX, Li SJ, Wei XY, Li L, Wu HQ, Ma X, Liu JS, Wu DP, Wu XJ (2023) Risk factors for Carbapenem-Resistant Enterobacteriaceae colonization and the effect on clinical outcomes and prognosis in allogeneic hematopoietic stem cell transplanted patients. Infect Drug Resist 16:6821\u20136831. https:\/\/doi.org\/10.2147\/IDR.S424048","journal-title":"Infect Drug Resist"},{"key":"5377_CR3","doi-asserted-by":"publisher","first-page":"5993","DOI":"10.2147\/IDR.S387615","volume":"15","author":"W Cao","year":"2022","unstructured":"Cao W, Zhang J, Bian Z, Li L, Zhang S, Qin Y, Wan D, Jiang Z, Zhang R (2022) Active screening of intestinal colonization of Carbapenem-Resistant Enterobacteriaceae for subsequent bloodstream infection in allogeneic hematopoietic stem cell transplantation. Infect Drug Resist 15:5993\u20136006. https:\/\/doi.org\/10.2147\/IDR.S387615","journal-title":"Infect Drug Resist"},{"issue":"6","key":"5377_CR4","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1080\/14787210.2021.1855143","volume":"19","author":"O Bupha-Intr","year":"2021","unstructured":"Bupha-Intr O, Haeusler G, Chee L, Thursky K, Slavin M, Teh B (2021) CAR-T cell therapy and infection: a review. Expert Rev anti-infective Therapy 19(6):749\u2013758. https:\/\/doi.org\/10.1080\/14787210.2021.1855143","journal-title":"Expert Rev anti-infective Therapy"},{"issue":"4","key":"5377_CR5","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/ejh.13583","volume":"106","author":"A Mian","year":"2021","unstructured":"Mian A, Andrapalliyal N, Weathers AL, Pohlman B, Hill BT (2021) Late occurrence of progressive multifocal leukoencephalopathy after anti-CD19 chimeric antigen receptor T-cell therapy. Eur J Haematol 106(4):584\u2013588. https:\/\/doi.org\/10.1111\/ejh.13583","journal-title":"Eur J Haematol"},{"key":"5377_CR6","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.ijid.2021.09.061","volume":"112","author":"G Handley","year":"2021","unstructured":"Handley G, Khawaja F, Kondapi DS, Lee HJ, Kaufman GP, Neelapu SS, Fayad LE, Tummala S, Chi L, Strati P, Mulanovich VE (2021) Human herpesvirus 6 myelitis after chimeric antigen receptor T-cell therapy. Int J Infect Diseases: IJID : Official Publication Int Soc Infect Dis 112:327\u2013329. https:\/\/doi.org\/10.1016\/j.ijid.2021.09.061","journal-title":"Int J Infect Diseases: IJID : Official Publication Int Soc Infect Dis"},{"issue":"11","key":"5377_CR7","doi-asserted-by":"publisher","first-page":"6398","DOI":"10.1002\/jmv.27257","volume":"93","author":"E Cousin","year":"2021","unstructured":"Cousin E, Belicard F, Michel L, Pronier C, Lassalle N, Lamy T, Houot R, Lhomme F (2021) Severe cytomegalovirus disease with encephalitis after CAR-T cell therapy: a rare but potentially fatal complication. J Med Virol 93(11):6398\u20136403. https:\/\/doi.org\/10.1002\/jmv.27257","journal-title":"J Med Virol"},{"issue":"7","key":"5377_CR8","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/S1473-3099(19)30119-7","volume":"19","author":"MAV Marzolini","year":"2019","unstructured":"Marzolini MAV, Jaunmuktane Z, Roddie C, O\u2019Reilly M, Chiodini P, Peggs KS (2019) Toxoplasmosis initially presenting as neurological sequelae of chimeric antigen receptor T-cell therapy. Lancet Infect Dis 19(7):788. https:\/\/doi.org\/10.1016\/S1473-3099(19)30119-7","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"5377_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106777","volume":"61","author":"X Zhao","year":"2023","unstructured":"Zhao X, Li S, Zhang Y, Wang J, Wang C, Qin X, Hu F, Wang M (2023) Ceftazidime-avibactam-based combination therapy for hospital-acquired central nervous system infections caused by carbapenem-resistant Klebsiella pneumoniae. Int J Antimicrob Agents 61(5):106777. https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106777","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"5377_CR10","doi-asserted-by":"publisher","first-page":"978","DOI":"10.3324\/haematol.2019.238634","volume":"106","author":"JM Logue","year":"2021","unstructured":"Logue JM, Zucchetti E, Bachmeier CA, Krivenko GS, Larson V, Ninh D, Grillo G, Cao B, Kim J, Chavez JC, Baluch A, Khimani F, Lazaryan A, Nishihori T, Liu HD, Pinilla-Ibarz J, Shah BD, Faramand R, Coghill AE, Davila ML, Locke FL (2021) Immune reconstitution and associated infections following Axicabtagene Ciloleucel in relapsed or refractory large B-cell lymphoma. Haematologica 106(4):978\u2013986. https:\/\/doi.org\/10.3324\/haematol.2019.238634","journal-title":"Haematologica"},{"issue":"Supplement 1","key":"5377_CR11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-138865","volume":"136","author":"L Neill","year":"2020","unstructured":"Neill L, Mackenzie SC, Marzolini MAV, Townsend W, Ardeshna KM, Cwynarski K et al (2020) Steroid use, advanced stage disease and \u2265 3 lines of prior chemotherapy are associated with a higher risk of infection following CD19 CAR T-cell therapy for B-NHL: real world data from a large UK center. Blood 20. https:\/\/doi.org\/10.1182\/blood-2020-138865","journal-title":"Blood"},{"issue":"1","key":"5377_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1182\/bloodadvances.2020002732","volume":"5","author":"JH Baird","year":"2021","unstructured":"Baird JH, Epstein DJ, Tamaresis JS, Ehlinger Z, Spiegel JY, Craig J, Claire GK, Frank MJ, Muffly L, Shiraz P, Meyer E, Arai S, Brown JW, Johnston L, Lowsky R, Negrin RS, Rezvani AR, Weng WK, Latchford T, Sahaf B, Sidana S (2021) Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma. Blood Adv 5(1):143\u2013155. https:\/\/doi.org\/10.1182\/bloodadvances.2020002732","journal-title":"Blood Adv"},{"issue":"8","key":"5377_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41408-020-00346-7","volume":"10","author":"K Wudhikarn","year":"2020","unstructured":"Wudhikarn K, Palomba ML, Pennisi M, Garcia-Recio M, Flynn JR, Devlin SM, Afuye A, Silverberg ML, Maloy MA, Shah GL, Scordo M, Dahi PB, Sauter CS, Batlevi CL, Santomasso BD, Mead E, Seo SK, Perales MA (2020) Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma. Blood Cancer J 10(8):79. https:\/\/doi.org\/10.1038\/s41408-020-00346-7","journal-title":"Blood Cancer J"},{"issue":"5","key":"5377_CR14","doi-asserted-by":"publisher","first-page":"e004475","DOI":"10.1136\/jitc-2021-004475","volume":"10","author":"K Rejeski","year":"2022","unstructured":"Rejeski K, Perez A, Iacoboni G, Penack O, B\u00fccklein V, Jentzsch L, Mougiakakos D, Johnson G, Arciola B, Carpio C, Blumenberg V, Hoster E, Bullinger L, Locke FL, von Bergwelt-Baildon M, Mackensen A, Bethge W, Barba P, Jain MD, Subklewe M (2022) The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R\/R LBCL. J Immunother Cancer 10(5):e004475. https:\/\/doi.org\/10.1136\/jitc-2021-004475","journal-title":"J Immunother Cancer"},{"key":"5377_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00235","volume":"9","author":"AC Liberman","year":"2018","unstructured":"Liberman AC, Budzi\u00f1ski ML, Sokn C, Gobbini RP, Steininger A, Arzt E (2018) Regulatory and mechanistic actions of glucocorticoids on T and inflammatory cells. Front Endocrinol (Lausanne) 9:235. https:\/\/doi.org\/10.3389\/fendo.2018.00235","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"5377_CR16","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jmii.2021.02.006","volume":"54","author":"D Beauvais","year":"2021","unstructured":"Beauvais D, Karleskind O, Loridant S, Nyga R, Lamiaux M, Moreau AS, Morschhauser F, Mitra S, Yakoub-Agha I, Sendid B (2021) Potential role of tocilizumab in severe gastrointestinal barrier damage after CAR T-cell therapy. J Microbiol Immunol Infect 54(2):327\u2013330. https:\/\/doi.org\/10.1016\/j.jmii.2021.02.006","journal-title":"J Microbiol Immunol Infect"},{"issue":"10","key":"5377_CR17","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001422","volume":"70","author":"HR Higashino","year":"2021","unstructured":"Higashino HR, Marchi AP, Ruedas Martins RC, Bubach Carvalho L, Vieira Perdig\u00e3o Neto L, Farrel C\u00f4rtes M, de Nivaldo Oliveira F, Tarsia Duarte EL, Guimaraes T, Rossi F, Ferreira AM, Rocha V, Costa SF (2021) Carbapenem-resistant Klebsiella pneumoniae colonization and infection is associated with lower overall survival in a cohort of haematopoietic stem-cell transplantation patients: mechanism of resistance and virulence by whole-genome sequencing. J Med Microbiol 70(10):10.1099\/jmm.0.001422. https:\/\/doi.org\/10.1099\/jmm.0.001422","journal-title":"J Med Microbiol"},{"issue":"6","key":"5377_CR18","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.bbmt.2016.02.009","volume":"22","author":"J Bilinski","year":"2016","unstructured":"Bilinski J, Robak K, Peric Z, Marchel H, Karakulska-Prystupiuk E, Halaburda K, Rusicka P, Swoboda-Kopec E, Wroblewska M, Wiktor-Jedrzejczak W, Basak GW (2016) Impact of gut colonization by antibiotic-resistant bacteria on the outcomes of allogeneic hematopoietic stem cell transplantation: a retrospective, single-center study. Biology of blood and marrow transplantation\u202f: journal of the American Society for Blood and Marrow Transplantation 22(6):1087\u20131093. https:\/\/doi.org\/10.1016\/j.bbmt.2016.02.009","journal-title":"Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation"},{"issue":"6","key":"5377_CR19","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ijantimicag.2013.08.008","volume":"42","author":"C L\u00fcbbert","year":"2013","unstructured":"L\u00fcbbert C, Faucheux S, Becker-Rux D, Laudi S, D\u00fcrrbeck A, Busch T, Gastmeier P, Eckmanns T, Rodloff AC, Kaisers UX (2013) Rapid emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae: a single-centre experience. Int J Antimicrob Agents 42(6):565\u2013570. https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.08.008","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"5377_CR20","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1128\/AAC.02283-13","volume":"58","author":"C Tascini","year":"2014","unstructured":"Tascini C, Sbrana F, Flammini S, Tagliaferri E, Arena F, Leonildi A, Ciullo I, Amadori F, Di Paolo A, Ripoli A, Lewis R, Rossolini GM, Menichetti F, GENGUT Study Group (2014) Oral gentamicin gut decontamination for prevention of KPC-producing Klebsiella pneumoniae infections: relevance of concomitant systemic antibiotic therapy. Antimicrob Agents Chemother 58(4):1972\u20131976. https:\/\/doi.org\/10.1128\/AAC.02283-13","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"5377_CR21","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.jiac.2019.04.021","volume":"25","author":"H Kunishima","year":"2019","unstructured":"Kunishima H, Ishibashi N, Wada K, Oka K, Takahashi M, Yamasaki Y, Aoyagi T, Takemura H, Kitagawa M, Kaku M (2019) The effect of gut microbiota and probiotic organisms on the properties of extended spectrum beta-lactamase producing and carbapenem resistant Enterobacteriaceae including growth, beta-lactamase activity and gene transmissibility. J Infect Chemotherapy: Official J Japan Soc Chemother 25(11):894\u2013900. https:\/\/doi.org\/10.1016\/j.jiac.2019.04.021","journal-title":"J Infect Chemotherapy: Official J Japan Soc Chemother"},{"key":"5377_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2024.101229","volume":"68","author":"M Akhmedov","year":"2024","unstructured":"Akhmedov M, Espinoza JL (2024) Addressing the surge of infections by multidrug-resistant Enterobacterales in hematopoietic cell transplantation. Blood Rev 68:101229. https:\/\/doi.org\/10.1016\/j.blre.2024.101229","journal-title":"Blood Rev"},{"issue":"4","key":"5377_CR23","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41591-022-01702-9","volume":"28","author":"M Smith","year":"2022","unstructured":"Smith M, Dai A, Ghilardi G, Amelsberg KV, Devlin SM, Pajarillo R, Slingerland JB, Beghi S, Herrera PS, Giardina P, Clurman A, Dwomoh E, Armijo G, Gomes ALC, Littmann ER, Schluter J, Fontana E, Taur Y, Park JH, Palomba ML, Ruella M (2022) Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy. Nat Med 28(4):713\u2013723. https:\/\/doi.org\/10.1038\/s41591-022-01702-9","journal-title":"Nat Med"},{"issue":"1","key":"5377_CR24","doi-asserted-by":"publisher","first-page":"5313","DOI":"10.1038\/s41467-022-32960-3","volume":"13","author":"Y Hu","year":"2022","unstructured":"Hu Y, Li J, Ni F, Yang Z, Gui X, Bao Z, Zhao H, Wei G, Wang Y, Zhang M, Hong R, Wang L, Wu W, Mohty M, Nagler A, Chang AH, van den Brink MRM, Li MD, Huang H (2022) CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies. Nat Commun 13(1):5313. https:\/\/doi.org\/10.1038\/s41467-022-32960-3","journal-title":"Nat Commun"},{"issue":"4","key":"5377_CR25","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/s41591-023-02234-6","volume":"29","author":"CK Stein-Thoeringer","year":"2023","unstructured":"Stein-Thoeringer CK, Saini NY, Zamir E, Blumenberg V, Schubert ML, Mor U, Fante MA, Schmidt S, Hayase E, Hayase T, Rohrbach R, Chang CC, McDaniel L, Flores I, Gaiser R, Edinger M, Wolff D, Heidenreich M, Strati P, Nair R, Elinav E (2023) A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy. Nat Med 29(4):906\u2013916. https:\/\/doi.org\/10.1038\/s41591-023-02234-6","journal-title":"Nat Med"},{"issue":"8","key":"5377_CR26","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1182\/blood.2024025366","volume":"145","author":"R Prasad","year":"2025","unstructured":"Prasad R, Rehman A, Rehman L, Darbaniyan F, Blumenberg V, Schubert ML, Mor U, Zamir E, Schmidt S, Hayase T, Chang CC, McDaniel L, Flores I, Strati P, Nair R, Chihara D, Fayad LE, Ahmed S, Iyer SP, Wang M, Saini NY (2025) Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapy. Blood 145(8):823\u2013839. https:\/\/doi.org\/10.1182\/blood.2024025366","journal-title":"Blood"},{"issue":"3","key":"5377_CR27","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.annonc.2021.12.003","volume":"33","author":"PJ Hayden","year":"2022","unstructured":"Hayden PJ, Roddie C, Bader P, Basak GW, Bonig H, Bonini C, Chabannon C, Ciceri F, Corbacioglu S, Ellard R, Sanchez-Guijo F, J\u00e4ger U, Hildebrandt M, Hudecek M, Kersten MJ, K\u00f6hl U, Kuball J, Mielke S, Mohty M, Murray J, Yakoub-Agha I (2022) Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA). Ann Oncol 33(3):259\u2013275. https:\/\/doi.org\/10.1016\/j.annonc.2021.12.003","journal-title":"Ann Oncol"},{"issue":"6","key":"5377_CR28","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01906-21","volume":"10","author":"W Yuan","year":"2022","unstructured":"Yuan W, Xu J, Guo L, Chen Y, Gu J, Zhang H, Yang C, Yang Q, Deng S, Zhang L, Deng Q, Wang Z, Ling B, Deng D (2022) Clinical risk factors and microbiological and intestinal characteristics of carbapenemase-producing Enterobacteriaceae colonization and subsequent infection. Microbiol Spectr 10(6):e0190621. https:\/\/doi.org\/10.1128\/spectrum.01906-21","journal-title":"Microbiol Spectr"},{"issue":"10","key":"5377_CR29","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00845-19","volume":"63","author":"K Marimuthu","year":"2019","unstructured":"Marimuthu K, Ng OT, Cherng BPZ, Fong RKC, Pada SK, De PP, Ooi ST, Smitasin N, Thoon KC, Krishnan PU, Ang MLT, Chan DSG, Kwa ALH, Deepak RN, Chan YK, Chan YFZ, Huan X, Zaw Linn K, Tee NWS, Tan TY, CaPES Study Group (2019) Antecedent carbapenem exposure as a risk factor for non-carbapenemase-producing carbapenem-resistant Enterobacteriaceae and carbapenemase-producing Enterobacteriaceae. Antimicrob Agents Chemother 63(10):e00845-19. https:\/\/doi.org\/10.1128\/AAC.00845-19","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"5377_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40872-z","volume":"14","author":"AYG Yip","year":"2023","unstructured":"Yip AYG, King OG, Omelchenko O, Kurkimat S, Horrocks V, Mostyn P, Danckert N, Ghani R, Satta G, Jauneikaite E, Davies FJ, Clarke TB, Mullish BH, Marchesi JR, McDonald JAK (2023) Antibiotics promote intestinal growth of carbapenem-resistant Enterobacteriaceae by enriching nutrients and depleting microbial metabolites. Nat Commun 14(1):5094. https:\/\/doi.org\/10.1038\/s41467-023-40872-z","journal-title":"Nat Commun"},{"key":"5377_CR31","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jgar.2023.12.007","volume":"36","author":"S Gao","year":"2024","unstructured":"Gao S, Yan R, Zhang S, Li L, Zhang R, Fan J, Qin J, Peng Y, Wan D, Cao W, Bian Z (2024) Rectal culture could predict carbapenem-resistant organism bloodstream infection and reduce the mortality in haematological patients: a retrospective cohort study. J Glob Antimicrob Resist 36:96\u2013104. https:\/\/doi.org\/10.1016\/j.jgar.2023.12.007","journal-title":"J Glob Antimicrob Resist"},{"issue":"2","key":"5377_CR32","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/bmt.2014.231","volume":"50","author":"C Girmenia","year":"2015","unstructured":"Girmenia C, Rossolini GM, Piciocchi A, Bertaina A, Pisapia G, Pastore D, Sica S, Severino A, Cudillo L, Ciceri F, Scim\u00e8 R, Lombardini L, Viscoli C, Rambaldi A, Gruppo Italiano Trapianto Midollo Osseo (GITMO), Gruppo Italiano Trapianto Midollo Osseo GITMO (2015) Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy. Bone Marrow Transplant 50(2):282\u2013288. https:\/\/doi.org\/10.1038\/bmt.2014.231","journal-title":"Bone Marrow Transplant"},{"issue":"13","key":"5377_CR33","doi-asserted-by":"publisher","first-page":"e606","DOI":"10.1016\/S1470-2045(14)70344-4","volume":"15","author":"M Ruhnke","year":"2014","unstructured":"Ruhnke M, Arnold R, Gastmeier P (2014) Infection control issues in patients with haematological malignancies in the era of multidrug-resistant bacteria. Lancet Oncol 15(13):e606\u2013e619. https:\/\/doi.org\/10.1016\/S1470-2045(14)70344-4","journal-title":"Lancet Oncol"},{"key":"5377_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jgar.2023.08.006","volume":"35","author":"H Hu","year":"2023","unstructured":"Hu H, Wang H, Yu M, Feng H, Zhang S, Zhang Y, Shen P, Chen Y, Jiang Y, Yang Q, Qu T (2023) Clinical and microbiological characteristics of carbapenem-resistant Enterobacteriaceae causing post-operative central nervous system infections in China. J Glob Antimicrob Resist 35:35\u201343. https:\/\/doi.org\/10.1016\/j.jgar.2023.08.006","journal-title":"J Glob Antimicrob Resist"},{"issue":"1","key":"5377_CR35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jiac.2019.07.023","volume":"26","author":"Z Guanghui","year":"2020","unstructured":"Guanghui Z, Jing L, Guojun Z, Hong L (2020) Epidemiology and risk factors of neurosurgical bacterial meningitis\/encephalitis induced by carbapenem resistant Enterobacteriaceae. J Infect Chemotherapy: Official J Japan Soc Chemother 26(1):101\u2013106. https:\/\/doi.org\/10.1016\/j.jiac.2019.07.023","journal-title":"J Infect Chemotherapy: Official J Japan Soc Chemother"},{"key":"5377_CR36","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.2147\/IDR.S306222","volume":"14","author":"Q Zhou","year":"2021","unstructured":"Zhou Q, Wang H, Zhan T, Yang X, Wen L (2021) Successful treatment of ventriculitis caused by MDR\/XDR Gram-Negative Bacillus using Ceftazidime\/Avibactam: case series and literature review. Infect Drug Resist 14:1691\u20131701. https:\/\/doi.org\/10.2147\/IDR.S306222","journal-title":"Infect Drug Resist"},{"key":"5377_CR37","doi-asserted-by":"publisher","DOI":"10.1590\/S1678-9946201961069","volume":"61","author":"YC Patrial","year":"2019","unstructured":"Patrial YC, Tortorelli LP, Rodrigues ACS, Santos ICO, Volpe-Chaves CE, Capato GS, Barbosa GAR, Carvalho-Assef APD, Chang MR (2019) Post-neurosurgical meningitis caused by KPC-producing Klebsiella pneumoniae: report of two cases. Rev Inst Med Trop Sao Paulo 61:e69. https:\/\/doi.org\/10.1590\/S1678-9946201961069","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"5377_CR38","doi-asserted-by":"publisher","DOI":"10.1590\/S1678-9946202365023","volume":"65","author":"T Tunckale","year":"2023","unstructured":"Tunckale T, Kavak C, Safak B, Gonen A, Erdem I (2023) A case report of brain abscess caused by carbapenem-resistant Klebsiella pneumoniae. Rev Inst Med Trop Sao Paulo 65:e23. https:\/\/doi.org\/10.1590\/S1678-9946202365023","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"30","key":"5377_CR39","doi-asserted-by":"publisher","first-page":"e29635","DOI":"10.1097\/MD.0000000000029635","volume":"101","author":"J Li","year":"2022","unstructured":"Li J, Liu Y, Wu G, Wang H, Xu X (2022) Intravenous plus intraventricular tigecycline-amikacin therapy for the treatment of carbapenem-resistant Klebsiella pneumoniae ventriculitis: a case report. Medicine 101(30):e29635. https:\/\/doi.org\/10.1097\/MD.0000000000029635","journal-title":"Medicine"},{"issue":"1","key":"5377_CR40","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/jac\/dkx358","volume":"73","author":"A Holyk","year":"2018","unstructured":"Holyk A, Belden V, Lee JJ, Musick W, Keul R, Britz GW, Lin J (2018) Ceftazidime\/avibactam use for carbapenem-resistant Klebsiella pneumoniae meningitis: a case report. J Antimicrob Chemother 73(1):254\u2013256. https:\/\/doi.org\/10.1093\/jac\/dkx358","journal-title":"J Antimicrob Chemother"},{"issue":"13","key":"5377_CR41","doi-asserted-by":"publisher","first-page":"953","DOI":"10.2146\/ajhp170632","volume":"75","author":"N Gofman","year":"2018","unstructured":"Gofman N, To K, Whitman M, Garcia-Morales E (2018) Successful treatment of ventriculitis caused by Pseudomonas aeruginosa and carbapenem-resistant Klebsiella pneumoniae with i.v. ceftazidime-avibactam and intrathecal Amikacin. Am J health-system Pharmacy: AJHP\u202f: Official J Am Soc Health-System Pharmacists 75(13):953\u2013957. https:\/\/doi.org\/10.2146\/ajhp170632","journal-title":"Am J health-system Pharmacy: AJHP : Official J Am Soc Health-System Pharmacists"},{"issue":"4","key":"5377_CR42","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1080\/02688697.2018.1530729","volume":"37","author":"Y Chen","year":"2023","unstructured":"Chen Y, Liu L (2023) The treatment of nosocomial meningitis and brain abscess by carbapenem-resistant Klebsiella pneumonia. Br J Neurosurg 37(4):634\u2013636. https:\/\/doi.org\/10.1080\/02688697.2018.1530729","journal-title":"Br J Neurosurg"},{"issue":"4","key":"5377_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13040331","volume":"13","author":"LF Rezzonico","year":"2024","unstructured":"Rezzonico LF, Peracchi F, Vecchi M, Bassi G, Merli M, Bana NB, Travi G, Crippa F, Puoti M (2024) Meropenem-Vaborbactam for the treatment of post-neurosurgical meningitis caused by KPC producer Klebsiella Pneumoniae: a case report and review of the literature. Antibiotics 13(4):331. https:\/\/doi.org\/10.3390\/antibiotics13040331","journal-title":"Antibiotics"},{"issue":"5","key":"5377_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13050432","volume":"13","author":"R Rubino","year":"2024","unstructured":"Rubino R, Trizzino M, Pipit\u00f2 L, Sucato G, Santoro M, Maugeri R, Iacopino DG, Giammanco GM, Siragusa S, Cascio A (2024) A difficult case of ventriculitis in a 40-year-old woman with acute myeloid leukemia. Antibiotics 13(5):432. https:\/\/doi.org\/10.3390\/antibiotics13050432","journal-title":"Antibiotics"},{"key":"5377_CR45","doi-asserted-by":"publisher","unstructured":"Xu Y, Luo X, Yuan B, Liang P, Liu N, Dong D, Ge W, Gu Q (2024) The pharmacokinetics\/pharmacodynamics of ceftazidime\/avibactam for central nervous system infections caused by carbapenem-resistant Gram-negatives: a prospective study. J Antimicrob Chemother 79(4):820\u2013825. https:\/\/doi.org\/10.1093\/jac\/dkae035","DOI":"10.1093\/jac\/dkae035"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05377-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-025-05377-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05377-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T08:03:59Z","timestamp":1780128239000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-025-05377-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["5377"],"URL":"https:\/\/doi.org\/10.1007\/s10096-025-05377-1","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This case report was approved by the Medical Ethics Committee of the Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology. All methods were carried out in accordance with relevant guidelines and regulations, including the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from the parents.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The patients\u2019 parents granted us permission to publish this report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}